Medtronic
MDT
2,004 hedge funds and large institutions have $179B invested in Medtronic in 2021 Q2 according to their latest regulatory filings, with 145 funds opening new positions, 858 increasing their positions, 736 reducing their positions, and 92 closing their positions.
58% more first-time investments, than exits
New positions opened: 145 | Existing positions closed: 92
39% more capital invested
Capital invested by funds: $129B → $179B (+$49.7B)
17% more repeat investments, than reductions
Existing positions increased: 858 | Existing positions reduced: 736
15% more call options, than puts
Call options by funds: $892M | Put options by funds: $775M
6% more funds holding in top 10
Funds holding in top 10: 53 → 56 (+3)
1% more funds holding
Funds holding: 1,977 → 2,004 (+27)
2.06% less ownership
Funds ownership: 83.03% → 80.98% (-2.1%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$419M |
| 2 |
JP Morgan Chase
New York
|
+$418M |
| 3 |
Sanders Capital
West Palm Beach,
Florida
|
+$269M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$257M |
| 5 |
Two Sigma Advisers
New York
|
+$213M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
-$3.42B |
| 2 |
Bank of New York Mellon
New York
|
-$527M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
-$399M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$352M |
| 5 |
BlackRock
New York
|
-$268M |
MDT Hedge Fund Activity: Q2 2021 in Review
2,004 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q2 2021, worth a combined $179B — up 39% from $129B a quarter earlier.
Buyers outnumbered sellers: 145 funds opened new MDT positions and 92 closed out — a net gain of 53 holders — while 858 added to existing stakes and 736 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $419M. The largest seller was Financial Perspectives, cutting an estimated $3.42B.
- 2,004 institutional investors held Medtronic (MDT) as of Q2 2021, up from 1,977 in Q1 2021.
- Funds reported $179B of Medtronic stock for Q2 2021, up 39% quarter-over-quarter.
- 145 funds opened new Medtronic positions in Q2 2021 and 92 closed out, a net change of +53 holders.
- The largest Medtronic buyer in Q2 2021 was Capital Research Global Investors, an estimated $419M added.
- The largest Medtronic seller in Q2 2021 was Financial Perspectives, an estimated $3.42B sold.
Based on aggregated 13F filings for Q2 2021.